CXCR4 and neoplasm: Using in vivo models and the B-ALL cell lines REH and Nalm-6, the tetraspanin CD9 was shown to modulate CXCR4-mediated cell migration involving Rac1 signaling, as well as tumor cell survival and homing into the BM and testes (137).